Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Large cap biotech stocks performed much better than small and mid caps last year. Will this development continue or is a change in sight? Will M&A activity increase again this year and which indications and technologies will be in particular focus? These and other questions are explored in the video update with Dr. Daniel Koller, Head of the Investment Management Team.

«We expect M&A activity to increase in the coming quarters.»

Large cap biotech stocks performed much better than small and mid caps last year. Will this development continue or is a change in sight? Will M&A activity increase again this year and which indications and technologies will be in particular focus? These and other questions are explored in the video update with Dr. Daniel Koller, Head of the Investment Management Team.
17.02.2023 - Daniel Koller
BB Biotech – Video Update mit Daniel Koller (en)

These investment strategies might interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 26.76%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993